GLASTONBURY

We Are Here For You

Welcome to Glastonbury

We are very excited to be joining the Glastonbury community! We want to provide hope for depression and OCD in every area that needs us. Incorporated in 1693, Glastonbury is one of Connecticut’s oldest municipalities. Glastonbury is proud to be well known for its outstanding public education, excellent municipal management and exceptionally high quality of life. Achieve TMS East is located at 703 Hebron Ave. 2nd Floor, Glastonbury, CT 06033

Depression Treatment in Glastonbury

Taking part in all that Glastonbury has to offer isn’t easy when dealing with Depression and OCD. This is why we’ve opened Achieve TMS East in Glastonbury. Our center proudly offers the revolutionary Deep TMS therapy (transcranial magnetic stimulation)—an FDA-approved and highly effective form of Depression and OCD treatment. As Massachusetts’s largest Deep TMS providers, our clinical staff has helped hundreds of patients!

Request a Consultation

TMS Therapy in Glastonbury is an Easy Process

Short bursts of magnetic pulses are directed to the limbic system or mood center of the brain. Patients typically start to see positive results in two or three weeks. There’s no need for anesthesia, and there are none of the systemic side effects associated with medications. TMS therapy in Glastonbury is simple. Just come to our conveniently located office for a 20-minute session each day and then drive back to work or home. That’s it. TMS therapy could be the hope you’re looking for. You won’t know unless you try.

Achieve TMS East is New England’s Largest dTMS Provider

Collectively with Achieve TMS Central, Achieve TMS East is a leading provider of deep TMS therapy for the treatment for depression in the U.S. Take the next step. Regain joy. Give us a call at 413-216-0108 for a free wellness consultation or email us at info@achievetmseast.com to learn more.

Glastonbury

703 Hebron Ave. 2nd floor
Glastonbury Connecticut 06033
USA

Additional Therapy with TMS

TMS was cleared in the United States by the FDA back in 2008 to help patients with treatment-resistant depression. In 2013 deep TMS was cleared by the FDA to help with this. Deep TMS was FDA approved in 2018 for OCD. It has also been CE approved in Europe for the treatment of bipolar disorder, PTSD, chronic pain, and adult ADHD.

Including studies and TMS treatment worldwide, TMS has helped with the following:

Insurance Coverage for TMS

Insurance accepted for treating Depression, specifically TMS therapy, has more than doubled in the last few years, a sign that insurance companies must see cost savings in a treatment method for major depressive disorder (MDD) that works more efficiently than the traditional regimen alone. Patients who continually suffer from the debilitating effects of medication-resistant depression may acquire other health conditions as a result, such as a substance abuse disorder or unhealthy weight gain, to name a few. The fact that more and more insurance companies are providing coverage for TMS indicates a cost benefit to the insurer, thus the broadening of benefits.

The following are some of the insurance plans currently working with Achieve TMS East: Aetna, BCBS, BMC, Cigna, Commonwealth Care Alliance, Fallon Health, GIC, Harvard Pilgrim, Husky, Masshealth PCC Plan, Medicare, Neighborhood Health Plan, One Care, Tricare, Tufts Health Plan, and United Health Care. If you don’t see your plan listed, please call and ask us about yours today.